683 Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70,000	Closed	-$317K	–	199
2023 Q1	$317K	Sell	70,000 -117,997	-63%	-$535K	0.02%	118
2022 Q4	$776K	Sell	187,997 -166,931	-47%	-$689K	0.07%	116
2022 Q3	$1.14M	Buy	354,928 +106,128	+43%	+$340K	0.09%	114
2022 Q2	$488K	Sell	248,800 -1,200	-0.5%	-$2.35K	0.03%	157
2022 Q1	$1.01M	Sell	250,000 -6,620	-3%	-$26.8K	0.05%	150
2021 Q4	$2.77M	Hold	256,620	–	–	0.1%	104
2021 Q3	$2.96M	Hold	256,620	–	–	0.12%	90
2021 Q2	$2.52M	Buy	256,620 +36,484	+17%	+$358K	0.09%	103
2021 Q1	$3.22M	Hold	220,136	–	–	0.17%	75
2020 Q4	$4.71M	Hold	220,136	–	–	0.22%	58
2020 Q3	$3.34M	Hold	220,136	–	–	0.24%	57
2020 Q2	$2.83M	Buy	220,136 +939	+0.4%	+$12.1K	0.23%	55
2020 Q1	$2.03M	Sell	219,197 -5,934	-3%	-$54.8K	0.24%	56
2019 Q4	$3M	Buy	225,131 +30,847	+16%	+$411K	0.34%	43
2019 Q3	$1.72M	Buy	194,284 +83,025	+75%	+$736K	0.19%	52
2019 Q2	$1.59M	Hold	111,259	–	–	0.14%	70
2019 Q1	$3.66M	Sell	111,259 -5,408	-5%	-$178K	0.33%	47
2018 Q4	$6.93M	Buy	+116,667	New	+$6.93M	0.42%	27
2018 Q3	–	Sell	-133,333	Closed	-$16.4M	–	153
2018 Q2	$16.4M	Buy	133,333 +25,000	+23%	+$3.07M	1.11%	15
2018 Q1	$9.69M	Hold	108,333	–	–	0.86%	25
2017 Q4	$6.01M	Hold	108,333	–	–	0.51%	33
2017 Q3	$4.58M	Buy	108,333 +8,466	+8%	+$358K	0.48%	37
2017 Q2	$4.21M	Buy	99,867 +46,243	+86%	+$1.95M	0.62%	37
2017 Q1	$3M	Buy	53,624 +3,624	+7%	+$203K	0.47%	33
2016 Q4	$1.91M	Buy	+50,000	New	+$1.91M	0.14%	41